169:@0.890196:0.957873:0.914685:0.957873:0.914685:0.938882:0.890196:0.938882:0.007305:0.008593:0.008591
6:@0.941813:0.497523:0.963291:0.497523:0.963291:0.450045:0.941813:0.450045:0.021478
TARGETED LONG-READ SEQUENCING PROVIDES PERSONALIZED BIOMARKERS FOR:@0.410650:0.057372:0.882354:0.057372:0.882354:0.040253:0.410650:0.040253:0.005566:0.007919:0.008311:0.008404:0.006985:0.006387:0.006985:0.008423:0.002988:0.006481:0.008442:0.008759:0.008404:0.005155:0.008423:0.006985:0.007919:0.008423:0.002988:0.007807:0.006985:0.008442:0.008367:0.006985:0.008759:0.008255:0.003511:0.008759:0.008404:0.002988:0.008050:0.008307:0.008330:0.007620:0.003511:0.008423:0.006871:0.007807:0.002988:0.008050:0.006985:0.008348:0.007807:0.008442:0.008759:0.007919:0.006481:0.003511:0.006630:0.006985:0.008423:0.002988:0.008236:0.003511:0.008442:0.011112:0.007919:0.008423:0.008031:0.006985:0.008347:0.007807:0.002988:0.006593:0.008442:0.008423
MINIMAL RESIDUAL DISEASE TRACING IN PEDIATRIC LEUKEMIA:@0.521755:0.073247:0.882541:0.073247:0.882541:0.056128:0.521755:0.056128:0.011112:0.003511:0.008759:0.003511:0.011112:0.007919:0.006292:0.002988:0.008423:0.006873:0.007807:0.003511:0.008423:0.008255:0.007919:0.006294:0.002988:0.008423:0.003511:0.007807:0.006985:0.007712:0.007807:0.006985:0.002988:0.006387:0.008423:0.007863:0.008255:0.003511:0.008759:0.008404:0.002988:0.003511:0.008759:0.002988:0.008050:0.006985:0.008423:0.003511:0.007095:0.006387:0.008423:0.003511:0.008255:0.002988:0.006481:0.006985:0.008367:0.008031:0.006985:0.011112:0.003511:0.007919
PAM:@0.723500:0.187293:0.692716:0.187293:0.692716:0.173239:0.723500:0.173239:-0.007415:-0.010062:-0.013307
PAM:@0.723500:0.253797:0.692716:0.253797:0.692716:0.239744:0.723500:0.239744:-0.007415:-0.010062:-0.013307
unknown:@0.591876:0.120329:0.657751:0.120329:0.657751:0.106275:0.591876:0.106275:0.009120:0.009186:0.008044:0.009186:0.008971:0.012182:0.009186
known:@0.729522:0.120329:0.777086:0.120329:0.777086:0.106275:0.729522:0.106275:0.008041:0.009186:0.008969:0.012182:0.009186
unknown:@0.591876:0.175351:0.657751:0.175351:0.657751:0.161297:0.591876:0.161297:0.009120:0.009186:0.008044:0.009186:0.008971:0.012182:0.009186
known:@0.729522:0.175351:0.777086:0.175351:0.777086:0.161297:0.729522:0.161297:0.008041:0.009186:0.008969:0.012182:0.009186
unknown:@0.591876:0.242441:0.657751:0.242441:0.657751:0.228387:0.591876:0.228387:0.009120:0.009186:0.008044:0.009186:0.008971:0.012182:0.009186
known:@0.746153:0.242441:0.793722:0.242441:0.793722:0.228387:0.746153:0.228387:0.008044:0.009186:0.008971:0.012182:0.009186
Cas9:@0.754528:0.152166:0.787033:0.152166:0.787033:0.138112:0.754528:0.138112:0.009482:0.007978:0.006554:0.008491
PAM:@0.274385:0.162880:0.305171:0.162880:0.305171:0.148826:0.274385:0.148826:0.007415:0.010063:0.013307
PAM:@0.274385:0.228484:0.305171:0.228484:0.305171:0.214430:0.274385:0.214430:0.007415:0.010063:0.013307
known:@0.224747:0.120329:0.272316:0.120329:0.272316:0.106275:0.224747:0.106275:0.008044:0.009186:0.008971:0.012182:0.009186
unknown:@0.362389:0.120329:0.428263:0.120329:0.428263:0.106275:0.362389:0.106275:0.009120:0.009186:0.008042:0.009186:0.008971:0.012182:0.009186
known:@0.224747:0.175258:0.272316:0.175258:0.272316:0.161204:0.224747:0.161204:0.008044:0.009186:0.008971:0.012182:0.009186
unknown:@0.362389:0.175258:0.428263:0.175258:0.428263:0.161204:0.362389:0.161204:0.009120:0.009186:0.008042:0.009186:0.008971:0.012182:0.009186
known:@0.213227:0.241809:0.260796:0.241809:0.260796:0.227755:0.213227:0.227755:0.008044:0.009186:0.008971:0.012182:0.009186
unknown:@0.362389:0.241809:0.428263:0.241809:0.428263:0.227755:0.362389:0.227755:0.009120:0.009186:0.008042:0.009186:0.008971:0.012182:0.009186
Cas9:@0.214303:0.151909:0.246810:0.151909:0.246810:0.137855:0.214303:0.137855:0.009484:0.007978:0.006554:0.008491
Cas9:@0.163192:0.221360:0.195699:0.221360:0.195699:0.207306:0.163192:0.207306:0.009484:0.007978:0.006554:0.008491
Cas9:@0.806996:0.222260:0.839501:0.222260:0.839501:0.208206:0.806996:0.208206:0.009482:0.007978:0.006554:0.008491
PAM:@0.274385:0.162880:0.305171:0.162880:0.305171:0.148826:0.274385:0.148826:0.007415:0.010063:0.013307
knownn:@0.224747:0.175260:0.272317:0.175260:0.272317:0.161206:0.224747:0.161206:0.008044:0.009186:0.008971:0.012182:0.000000:0.009186
Cas9:@0.214295:0.151913:0.246802:0.151913:0.246802:0.137859:0.214295:0.137859:0.009484:0.007978:0.006554:0.008491
PAM:@0.723500:0.187293:0.692716:0.187293:0.692716:0.173239:0.723500:0.173239:-0.007415:-0.010062:-0.013307
known:@0.729522:0.175351:0.777088:0.175351:0.777088:0.161297:0.729522:0.161297:0.008041:0.009186:0.008971:0.012182:0.009186
k:@0.729522:0.175351:0.737285:0.175351:0.737285:0.161297:0.729522:0.161297:0.007763
Cas9:@0.754532:0.152166:0.787037:0.152166:0.787037:0.138112:0.754532:0.138112:0.009482:0.007978:0.006554:0.008491
Supplementary Figure 1: Schematic overview of targeted and directional sequencing. (A) :@0.147059:0.293728:0.826936:0.293728:0.826936:0.276438:0.147059:0.276438:0.008554:0.009730:0.009600:0.009637:0.004856:0.007583:0.014810:0.007583:0.009861:0.005771:0.007900:0.007657:0.008180:0.006854:0.009488:0.005080:0.008797:0.009730:0.006761:0.007751:0.006854:0.008927:0.004445:0.006854:0.008927:0.007433:0.009637:0.007583:0.014810:0.007807:0.005752:0.005155:0.007527:0.006854:0.009579:0.007863:0.007583:0.007657:0.008404:0.005155:0.008255:0.011990:0.006854:0.009264:0.005678:0.006854:0.005771:0.007900:0.006929:0.008423:0.007844:0.005622:0.007956:0.009712:0.006854:0.007902:0.009955:0.009712:0.006854:0.009712:0.005080:0.006761:0.007956:0.007639:0.005752:0.005153:0.009265:0.009955:0.008141:0.004781:0.006854:0.006742:0.007956:0.009224:0.009805:0.007585:0.009955:0.007527:0.005080:0.009786:0.008442:0.004445:0.006854:0.006238:0.012345:0.006238:0.003287
Known :@0.830469:0.293728:0.885714:0.293728:0.885714:0.277060:0.830469:0.277060:0.011841:0.009488:0.008890:0.012046:0.009618:0.003362
sequence adjacent to the unknown sequence of interest is necessary for assay design. :@0.147059:0.308280:0.741680:0.308280:0.741680:0.291612:0.147059:0.291612:0.006443:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007396:0.004576:0.007601:0.009039:0.004314:0.007601:0.007359:0.007396:0.009320:0.005267:0.004576:0.005080:0.009039:0.004576:0.005416:0.009245:0.007396:0.004576:0.009338:0.009712:0.008759:0.009488:0.008890:0.012046:0.009618:0.004576:0.006443:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007396:0.004576:0.008871:0.005080:0.004576:0.004594:0.009320:0.005080:0.007396:0.006089:0.007396:0.006145:0.005267:0.004576:0.004594:0.006275:0.004576:0.009488:0.007452:0.007359:0.007396:0.006163:0.006499:0.007433:0.006873:0.007956:0.004576:0.004929:0.008873:0.006387:0.004576:0.007601:0.006163:0.006498:0.007304:0.007956:0.004576:0.009264:0.007396:0.006219:0.004594:0.008068:0.009618:0.003679:0.003362
(B):@0.742821:0.308280:0.766559:0.308280:0.766559:0.290990:0.742821:0.290990:0.006238:0.011262:0.006238
 Cas9 (grey box) :@0.766559:0.308280:0.885731:0.308280:0.885731:0.291612:0.766559:0.291612:0.004576:0.012252:0.007601:0.006275:0.008535:0.004576:0.005678:0.008068:0.006089:0.007637:0.007956:0.004576:0.009207:0.008853:0.008255:0.005678:0.003362
is targeted through crRNAs (line) and the PAM sequence to the known sequence and introduces a double-:@0.147059:0.322833:0.882329:0.322833:0.882329:0.306164:0.147059:0.306164:0.004594:0.006275:0.003754:0.005360:0.007433:0.006238:0.007900:0.007471:0.005080:0.007452:0.009320:0.003754:0.005416:0.009376:0.006089:0.008853:0.009338:0.008124:0.009376:0.003754:0.007359:0.006387:0.010944:0.012607:0.011934:0.006275:0.003754:0.005678:0.004296:0.004594:0.009486:0.007396:0.005678:0.003754:0.007433:0.009488:0.009320:0.003754:0.005416:0.009245:0.007396:0.003754:0.008386:0.012214:0.016043:0.003754:0.006443:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007396:0.003754:0.005080:0.009039:0.003754:0.005416:0.009245:0.007396:0.003754:0.008759:0.009488:0.008890:0.012046:0.009618:0.003754:0.006442:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007396:0.003754:0.007433:0.009488:0.009320:0.003754:0.004594:0.009320:0.005267:0.006089:0.009226:0.009039:0.009282:0.007359:0.007396:0.006275:0.003754:0.007601:0.003754:0.009264:0.008853:0.009284:0.008927:0.004238:0.007396:0.006163
strand break (scissors) in the DNA. :@0.147059:0.337385:0.392542:0.337385:0.392542:0.320716:0.147059:0.320716:0.006145:0.005267:0.006462:0.007433:0.009488:0.009320:0.003549:0.008853:0.006089:0.007601:0.007695:0.008610:0.003549:0.005678:0.006443:0.007359:0.004594:0.006161:0.006443:0.008871:0.006240:0.006275:0.005678:0.003549:0.004594:0.009618:0.003549:0.005416:0.009245:0.007396:0.003549:0.012905:0.012607:0.012214:0.003679:0.003362
(C):@0.392744:0.337385:0.417303:0.337385:0.417303:0.320094:0.392744:0.320094:0.006238:0.012084:0.006238
 Cas9 blocks the PAM-distal side and sequencing reads (arrows) are :@0.417303:0.337385:0.885686:0.337385:0.885686:0.320716:0.417303:0.320716:0.003549:0.012250:0.007601:0.006275:0.008535:0.003549:0.008927:0.004240:0.009226:0.007172:0.008610:0.006275:0.003549:0.005416:0.009245:0.007396:0.003549:0.008386:0.012214:0.016043:0.006163:0.009320:0.004594:0.006143:0.005360:0.007695:0.004296:0.003549:0.006219:0.004538:0.009264:0.007396:0.003549:0.007433:0.009488:0.009320:0.003549:0.006443:0.007450:0.008759:0.009282:0.007396:0.009490:0.007359:0.004594:0.009376:0.008068:0.003549:0.006089:0.007601:0.007601:0.009320:0.006275:0.003549:0.005678:0.007433:0.006387:0.006089:0.008890:0.012046:0.006275:0.005678:0.003549:0.007433:0.006089:0.007396:0.003362
directed towards the unknown sequence.:@0.147059:0.353554:0.429314:0.353554:0.429314:0.336885:0.147059:0.336885:0.009320:0.004594:0.006089:0.007452:0.007452:0.005080:0.007452:0.009320:0.003362:0.005078:0.008890:0.012046:0.007433:0.006089:0.009320:0.006275:0.003362:0.005416:0.009245:0.007396:0.003362:0.009338:0.009712:0.008759:0.009488:0.008890:0.012046:0.009618:0.003362:0.006443:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007153:0.003679
 :@0.429314:0.354040:0.433049:0.354040:0.433049:0.335519:0.429314:0.335519:0.003735
Supplementary Figure 2: Reciprocal KMT2A fusion reads within the MLLT2 locus (B-ALL5).:@0.147059:0.660181:0.845631:0.660181:0.845631:0.642890:0.147059:0.642890:0.008554:0.009730:0.009600:0.009637:0.004856:0.007583:0.014810:0.007583:0.009861:0.005771:0.007900:0.007657:0.008180:0.005752:0.009488:0.005080:0.008797:0.009730:0.006761:0.007751:0.005752:0.008927:0.004445:0.005752:0.011451:0.007954:0.007527:0.005080:0.009525:0.006761:0.009618:0.007695:0.008143:0.004781:0.005752:0.012476:0.015763:0.011075:0.008927:0.012345:0.005752:0.005584:0.009674:0.006462:0.005155:0.009264:0.009955:0.005752:0.006761:0.007937:0.008068:0.009656:0.006574:0.005752:0.012233:0.005080:0.005939:0.009637:0.005080:0.009955:0.005752:0.005939:0.009637:0.007751:0.005752:0.015763:0.009712:0.008516:0.011075:0.008927:0.005752:0.004854:0.009618:0.007639:0.009674:0.006574:0.005752:0.006238:0.011262:0.005902:0.012345:0.009712:0.009712:0.008927:0.006238:0.004445
 IGV :@0.845702:0.660181:0.885707:0.660181:0.885707:0.643512:0.845702:0.643512:0.005883:0.005584:0.012831:0.012345:0.003362
screenshot of the B-ALL5 sample of fusion-spanning reads supporting the MLLT2-KMT2A fusion :@0.147059:0.674733:0.837322:0.674733:0.837322:0.658064:0.147059:0.658064:0.006443:0.007359:0.006089:0.007452:0.007396:0.009506:0.006182:0.009245:0.008853:0.005267:0.004165:0.008873:0.005080:0.004165:0.005416:0.009245:0.007396:0.004165:0.010347:0.006163:0.012214:0.009506:0.009506:0.008535:0.004165:0.006499:0.007433:0.014138:0.009133:0.004240:0.007396:0.004165:0.008871:0.005080:0.004165:0.005211:0.009338:0.006219:0.004538:0.008871:0.009618:0.006163:0.006145:0.009301:0.007433:0.009618:0.009618:0.004594:0.009376:0.008068:0.004165:0.006089:0.007601:0.007601:0.009320:0.006275:0.004165:0.006145:0.009058:0.009039:0.009413:0.008871:0.006516:0.005267:0.004594:0.009376:0.008068:0.004165:0.005416:0.009245:0.007396:0.004165:0.016043:0.009506:0.008236:0.010926:0.008535:0.006163:0.011897:0.016043:0.010926:0.008535:0.012214:0.004165:0.005211:0.009338:0.006219:0.004538:0.008871:0.009618:0.003362
(blue) :@0.838108:0.674733:0.885640:0.674733:0.885640:0.657443:0.838108:0.657443:0.006238:0.009432:0.004781:0.009805:0.007751:0.006238:0.003287
and KMT2A-MLLT2 fusion :@0.147059:0.690902:0.345121:0.690902:0.345121:0.674233:0.147059:0.674233:0.007433:0.009488:0.009320:0.003362:0.011897:0.016043:0.010926:0.008535:0.011131:0.006163:0.016043:0.009506:0.008234:0.010926:0.008535:0.003362:0.005211:0.009338:0.006219:0.004538:0.008871:0.009618:0.003362
(red):@0.345120:0.690902:0.382025:0.690902:0.382025:0.673611:0.345120:0.673611:0.006238:0.006761:0.007956:0.009712:0.006238
 within the MLLT2 locus. Note that reads start 531 bp apart. :@0.382024:0.690902:0.795163:0.690902:0.795163:0.674233:0.382024:0.674233:0.003362:0.012046:0.004314:0.005416:0.009376:0.004594:0.009618:0.003362:0.005414:0.009245:0.007396:0.003362:0.016043:0.009506:0.008236:0.010926:0.008535:0.003362:0.004240:0.009226:0.007452:0.009338:0.006275:0.003679:0.003362:0.012698:0.008855:0.005080:0.007396:0.003362:0.005414:0.009320:0.007209:0.005267:0.003362:0.006089:0.007601:0.007601:0.009320:0.006275:0.003362:0.006145:0.005360:0.007433:0.006518:0.005267:0.003362:0.008535:0.008535:0.008535:0.003362:0.008834:0.009226:0.003362:0.007209:0.009301:0.007433:0.006518:0.005267:0.003679:0.003362